여드름 치료 시장 예측(-2030년) : 제품별, 여드름 유형별, 약물 유형별, 치료법별, 투여 경로별, 최종 사용자별, 지역별 세계 분석

According to Stratistics MRC, the Global Acne Treatment Market is accounted for $11.1 billion in 2023 and is expected to reach $18.0 billion by 2030 growing at a CAGR of 7.1% during the forecast period. Clogged skin pores and openings, including hair follicles, are the cause of acne, a skin-related condition. Teenagers and those in their early adult years are the key demographics that exhibit this arrangement. This is an extremely prevalent skin condition that affects all skin types regardless of age. Antibiotics and retinoids are used in the treatment of this type of skin condition. Even though there is no certainty that treating these skin conditions would provide the desired effects, the industry has long dominated this field due to its cosmetic value.

According to the National Center for Biotechnology Information (NCBI), the prevalence of acne affected 9.4% of the global population in 2022. It is the eighth most prevalent disease in the world.

Market Dynamics:

Driver:

Increasing prevalence of acne

Skin disorders affect a large percentage of people. The worldwide public is becoming more aware of acne products and accessible treatment choices due to the advent of numerous products used for the treatment, such as retinoids, isotretinoids, and oral and topical antibiotics. Therefore, it is anticipated that rising patient awareness would promote market expansion. Effective product marketing to pique the interest of the intended audience is also a key component in driving market expansion.

Restraint:

Concerns about product safety

Treatments for acne might have different side effects according on the dosage and mode of administration. Skin irritation and dryness are the most frequent adverse effects of topical acne medications. More severe adverse effects are possible with oral medicines. Antibiotics may cause nausea or vomiting, as well as dizziness and light headedness. It is anticipated that the safety concerns surrounding acne treatment solutions would impede market expansion.

Opportunity:

Increasing awareness

The demand for minimally invasive cosmetic treatment treatments is increasing. Dermatologists would rather use topical treatments or less invasive techniques to address skin conditions than surgical ones. The need for treatments connected to face and skin-related issues is rising as a result of better decision-making, improved patient-physician connections, and well-documented procedures. This has prompted the use of less painful cosmetic combination treatment methods.

Threat:

High cost of treatment

Effective acne treatments can occasionally be costly, particularly when it comes to prescription drugs or procedures like laser therapy. This is a serious drawback for people with little resources or no insurance. Treatments for acne might not be a one-time expense. The overall cost of some procedures is increased by the need for regular maintenance or follow-up appointments. These factors are hampering the growth of the market.

COVID-19 Impact:

The epidemic slowed the rise of acne medications since fewer people worldwide were seeking treatment. Leading companies in the industry experienced significant revenue losses as a result of COVID-19. Drug sales were also impacted by reduced manufacturing, redistributing healthcare spending, broken supply chains, shutting dermatological clinics, and other issues. The rise in acne occurrences linked to extended usage of medical face masks further contributed to the demand for pharmaceuticals.

The therapeutic devices segment is expected to be the largest during the forecast period

The therapeutic devices segment is expected to be the largest during the forecast period. The development of therapeutic gadgets for the treatment of acne is propelling this industry's expansion. Reducing the visibility of scars from previous acne episodes is the goal of laser therapy for acne scars. Continuous light therapy is applied to the skin's dermis layer to break up scar tissue and promote the growth of new, healthy skin cells to replace the damaged tissue.

The retinoid segment is expected to have the highest CAGR during the forecast period

The retinoid segment is expected to have the highest CAGR during the forecast period. Retinoids are now widely used by people to clear their skin of excess oil and dust that has clogged their open pores. The method is a large market sector since it is regarded as safe and has little negative effects. They function by stopping the main cause of acne, dead skin cells, from obstructing pores. By encouraging cell turnover, retinoid production keeps the pores from becoming clogged.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to the region's increasing majority of acne and growing consumer problems related to beauty. The market will grow as a result of the introduction of new products by significant regional companies and a notable increase in the patient population. The market share will increase to a bigger volume as innovative treatments and solutions are used more frequently.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period due to rising awareness among the population about several drugs combined with the increasing number of companies entering the market. The greatest customer base for a variety of cosmetic goods created to achieve clean skin is found in this region. Due to the climate, hyperpigmentation has also been identified as a significant issue in this area. Moreover, growth would be fueled by consumers' increasing medicine usage over the projection period.

Key players in the market:

Some of the key players in Acne Treatment market include Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Leo Pharma A/S, Stiefel Laboratories, Inc., Bayer AG, Roche Holding AG, Bausch Health Companies Inc., Galderma Laboratories, Hoffman La Roche Ltd, Pfizer Inc., Valeant Pharmaceutical International, Inc., GlaxoSmithKline Plc., Cutera Inc., Vyne Therapeutics Inc., Botanix Pharmaceuticals, ABBVIE INC., Candela Corporation and Almirall, S.A.

Key Developments:

In July 2022, Glenmark Pharmaceuticals launched a new acne drug, MINYM gel, in India. This is India's first topical Minocycline 4% Gel to treat acne.

In March 2022, Galderma introduced its breakthrough skincare cream, Twyneo to treat moderate to severe facial acne, to the U.S. market at the American Academy of Dermatology (AAD) Annual Meeting.

In January 2022, GALDERMA announced to receive its antitrust clearance from the U.S. authorities after completing the acquisition of ALASTIN Skincare, Inc. for developing innovative and clinically-tested physician-dispensed skincare products.

Products Covered:

• Isotretinoi
• Antibiotics
• Retinoids
• Other Products

Acne Types Covered:

• Moderate
• Mild
• Moderate to Severe

Drug Types Covered:

• Prescription
• Over the Counter (OTC)

Treatments Covered:

• Devices
• Therapeutic Treatment
• Other Treatments

Route of Administrations Covered:

• Oral
• Injectable
• Topical

End Users Covered:

• MedSpa
• Dermatology Clinics
• Hospitals
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Acne Treatment Market, By Product

• 5.1 Introduction
• 5.2 Isotretinoi
• 5.3 Antibiotics
• 5.4 Retinoids
• 5.5 Other Products

6 Global Acne Treatment Market, By Acne Type

• 6.1 Introduction
• 6.2 Moderate
• 6.3 Mild
• 6.4 Moderate to Severe

7 Global Acne Treatment Market, By Drug Type

• 7.1 Introduction
• 7.2 Prescription
• 7.3 Over the Counter (OTC)

8 Global Acne Treatment Market, By Treatment

• 8.1 Introduction
• 8.2 Devices
  • 8.2.1 Radio frequency Devices
  • 8.2.2 Laser Devices
• 8.3 Therapeutic Treatment
  • 8.3.1 Anti-inflammatory Drugs
  • 8.3.2 Chemical Peels
  • 8.3.3 Hormonal Drugs
  • 8.3.4 Retinoid Therapy
  • 8.3.8 Antibiotics
• 8.4 Other Treatments

9 Global Acne Treatment Market, By Route of Administration

• 9.1 Introduction
• 9.2 Oral
• 9.3 Injectable
• 9.4 Topical

10 Global Acne Treatment Market, By End User

• 10.1 Introduction
• 10.2 MedSpa
• 10.3 Dermatology Clinics
• 10.4 Hospitals
• 10.5 Other End Users

11 Global Acne Treatment Market, By Geography

• 11.1 Introduction
• 11.2 North America
  • 11.2.1 US
  • 11.2.2 Canada
  • 11.2.3 Mexico
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 Italy
  • 11.3.4 France
  • 11.3.5 Spain
  • 11.3.6 Rest of Europe
• 11.4 Asia Pacific
  • 11.4.1 Japan
  • 11.4.2 China
  • 11.4.3 India
  • 11.4.4 Australia
  • 11.4.5 New Zealand
  • 11.4.6 South Korea
  • 11.4.7 Rest of Asia Pacific
• 11.5 South America
  • 11.5.1 Argentina
  • 11.5.2 Brazil
  • 11.5.3 Chile
  • 11.5.4 Rest of South America
• 11.6 Middle East & Africa
  • 11.6.1 Saudi Arabia
  • 11.6.2 UAE
  • 11.6.3 Qatar
  • 11.6.4 South Africa
  • 11.6.5 Rest of Middle East & Africa

12 Key Developments

• 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 12.2 Acquisitions & Mergers
• 12.3 New Product Launch
• 12.4 Expansions
• 12.5 Other Key Strategies

13 Company Profiling

• 13.1 Johnson & Johnson Services, Inc.
• 13.2 Teva Pharmaceutical Industries Ltd.
• 13.3 Leo Pharma A/S
• 13.4 Stiefel Laboratories, Inc.
• 13.5 Bayer AG
• 13.6 Roche Holding AG
• 13.7 Bausch Health Companies Inc.
• 13.8 Galderma Laboratories
• 13.9 Hoffman La Roche Ltd
• 13.10 Pfizer Inc.
• 13.11 Valeant Pharmaceutical International, Inc.
• 13.12 GlaxoSmithKline Plc.
• 13.13 Cutera Inc.
• 13.14 Vyne Therapeutics Inc.
• 13.15 Botanix Pharmaceuticals
• 13.16 ABBVIE INC.
• 13.17 Candela Corporation
• 13.18 Almirall, S.A.